Highlights of Past Projects

Acamprosate Treatment of Alcohol Dependence in a Family Medicine Setting: A Randomized, Double-Blind, Placebo-Controlled Study

Funding agency:  Subaward from Aurora Health Care (Forest Labs primary funder)
Time period: March 1, 2007 through February 28, 2010
Site P.I.:  Lisa Berger, CABHR Scientist and Associate Professor, HBSSW
Purpose:  This pilot study was designed to determine the efficacy of acamprosate for alcohol dependence in a family medicine/primary care setting using a minimal psychotherapeutic intervention. The study was a 12-week, randomized, double-blind, placebo-controlled trial comparing 666 mg acamprosate t.i.d. (three times a day) to placebo in patients with alcohol dependence. This same study was conducted at the University of North Carolina at Chapel Hill (UNC), and the data from the two sites was combined. The lead Principal Investigator of this study is Dr. James C. Garbutt, Professor of Psychiatry at UNC.

Collaborative AODA Service: Identifying Cost-Effective Models

Funding agency: Subaward from the Jewish Family Services (University of Wisconsin School of Medicine and Public Health primary funder)
Time Period:  December 1, 2009-November 30, 2010
Site P.I.:  Lisa Berger, CABHR Scientist and Associate Professor, HBSSW
Purpose:  In collaboration with Jewish Family Services (JFS), associate professor Lisa Berger received a subcontract award from JFS for the planning grant project titled “Collaborative AODA Service: Identifying Cost-Effective Models” funded by the Wisconsin Partnership Project, University of Wisconsin School of Medicine and Public Health, Hirsh Larkey Project Director. The project examined the incorporation and sharing of AODA services among three community-based organizations that provided high-quality and affordable mental health care.

Evaluation of Milwaukee County Drug Court

Funding agency:  Subaward from Milwaukee County (Bureau of Justice Administration (BJA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) primary funding agencies)
Time period:  September 1, 2009 through August 31, 2012
Site P.I.:  Michael Fendrich, CABHR Director and Wisconsin Distinguished Professor, HBSSW
Co-P.I.: Tom LeBel, CABHR Scientist and Associate Professor, HBSSW
Purpose:  To lead a process and performance evaluation of the Milwaukee County Circuit Court’s drug treatment court implementation.

Partnership for Responsible Retailers

Funding agency:  MillerCoors, LLC
Time period:  July 1, 2011-January 3, 2013
P.I.:  Tina Freiburger, CABHR Scientist and Associate Professor
Purpose:  Alcohol abuse is one of society’s most persistent and pervasive problems. Although the consumer is ultimately responsible for individual behavior, community partners such as alcohol retailers and distributors can assist the consumer in making informed decisions. This assistance is particularly important when retailers are confronted with problematic purchasing scenarios, including consumers who are: inebriated, underage, buying for a friend, or purchasing excessive quantities of alcohol. CABHR in partnership with Miller/Coors developed training vignettes for the purpose of providing information to alcohol retail workers that will equip them to better handle problem situations, thereby reducing alcohol related problems in the community.

RO1, Brief HIV and Alcohol Combined Intervention for Women

Funding agency: NIH/NIAAA
Time period: September 01, 2002 through August 31, 2007 (*no cost extension through August 31, 2008)
P.I.: Laura Otto-Salaj, CABHR Scientist and Associate Professor, HBSSW
Co-P.I.: Susan Rose, CABHR Scientist and Associate Professor, HBSSW
Purpose:  Heart to Heart was an exciting and innovative research study conducted in partnership with the former Milwaukee Women’s Center. CABHR Scientists who are involved with the project are Susan Rose, Co-PI; Mike Brondino, Co-Investigator; and Ron Cisler, Co-Investigator. Other Co-Investigators on the project are Allen Zweben, from Columbia University, and Lance Weinhardt from the Medical College of Wisconsin.
CABHR received a five-year grant from NIAAA to conduct this study, which provided state-of-the-art treatment for women with alcohol and/or other drug issues. In addition, participants were provided with counseling on other important women’s health issues. Participants received ten free individual counseling sessions using a therapeutic approach that incorporates treatment components from Cognitive Behavioral and Motivational Enhancement therapies along with other health related counseling. Study participants also received limited case management services. Upon completion of the therapy sessions, participants were expected to return to the office for five follow-up visits that take place once every three months over a one-year period.

SBIR, Hair Ethyl Glucuronide as a Long Term Alcohol Biomarker "Research on Undergraduate Student Health, (RUSH)"

Funding agency:  Subaward from the United Drug Testing Laboratories (NIH primary funder)
Time period: September 20, 2009 through August 31, 2012
Site P.I.:  Michael Fendrich, CABHR Director and Professor, HBSSW
Site Co.I.:  Lisa Berger, CABHR Scientist and Associate Professor, HBSSW
Statistician:  Daniel Fuhrmann, CABHR Associate Scientist
Purpose:  The RUSH study examined a chemical found in hair and fingernails called ethyl glucuronide (EtG). EtG is was tested in the RUSH study as a long-term (up to the three months) biomarker of alcohol consumption.

Supporting Jails in Providing Drug Abuse Services for Women

Funding agency:  Bureau of Justice Administration
Time period:  June 1, 2006-May 31, 2007 (*no cost extension through May 31, 2008)
P.I.:  Audrey Begun, CABHR Scientist (Ohio State) formally Professor, HBSSW
Co-P.I.:  Susan Rose, CABHR Scientist and Associate Professor, HBSSW
Co-I.:  Stan Stojkovic, Dean HBSSW
Co-I.:  Tom LeBel, CABHR Scientist and Associate Professor, Department of Criminal Justice, HBSSW
Purpose:  This project aimed to enhance the capacity of jails to address alcohol and other drug problems experienced by incarcerated women and women who are released back into the community. The research component of this project evaluated the extent to which state-of-the art interventions are implemented and the impact that the implementation has on addiction and criminal justice outcomes. Dramatic increases in the number of incarcerated women along with inadequate substance abuse screenings and interventions suggest that the proposed intervention and evaluation will fill a critical gap.

Western Wisconsin Collaborative for Children's Safety and Permanency

Funding agency:  Administration for Children, Youth and Families (Subaward - Wisconsin Department of Health and Family Services)
Time period:  January 1, 2008-December 31, 2012
P.I.: Joshua Mersky, CABHR Scientist (UIC) formally Associate Professor, HBSSW
Purpose:  Funded by the Administration for Children, Youth and Families, this study evaluated the effectiveness of the Western Collaborative for Children's Safety and Permanence (WCCSP). The WCCSP is an alliance of State, Regional, and County/Tribe-level partners who are committed to responding to the safety and permanency needs of children whose parents or caregivers abuse alcohol, methamphetamine, or other drugs.